Clinical Trials List
Protocol NumberCMHV370A12201
2021-11-01 - 2023-03-02
Phase II
Recruiting3
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Yao-Fan Fang 無
- 陳彥輔 無
- Ping-Han Tsai 無
- Yun Chen Tsai 無
- Shue-Fen Lo 無
- TianMing Zhan 無
- Yun Ju Huang 無
- 張哲慈 無
- Chen-I Hsieh 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 譚國棟 無
- 曾智偉 未分科
- 廖育婉 無
- 謝祖怡 無
- 謝佳偉 無
- 吳沂達 無
- Yi-Ming Chen 無
- HSIN-HUA CHEN 無
- 陳彥如 無
- WEN-NAN HUANG 無
- 林靖才 無
- 洪維廷 無
- Pin-Kuei Fu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
7-14 participants
-
Global
60 participants
